References
-
1) Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
-
2) Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of hepatocarcinoma.
-
3) Cerium oxide nanozyme attenuates periodontal bone destruction by inhibiting ROS-NFκB pathway.
-
4) Autophagy-inhibiting biomimetic nanodrugs enhance photothermal therapy and boost antitumor immunity.
-
5) Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer.
-
6) In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis.
-
7) Hierarchical microgroove/nanopore topography regulated cell adhesion to enhance osseointegration around intraosseous implants in vivo.
-
8) Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors.
-
9) Plant AFC2 kinase desensitizes thermomorphogenesis through modulation of alternative splicing.
-
10) The osteogenic response to chirality-patterned surface potential distribution of CFO/P (VDF-TrFE) membranes.
-
11) Progranulin improves neural development via the PI3K/Akt/GSK-3β pathway in the cerebellum of a VPA-induced rat model of ASD.
-
12) Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE.
-
13) Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer.
-
14) A small-molecule Skp1 inhibitor elicits cell death by p53-dependent mechanism.
-
15) METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma.